Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGXT | P21549 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.52 |
| ▸ | KDM1A | O60341 | 2/20 | 0.51 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | XBP1 | P17861 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29519635 | 1.00 | AGXT (0.57) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL10025804 | 0.87 | AGXT (0.45) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL29550893 | 0.85 | AGXT (0.53) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL22849632 | 0.85 | AGXT (0.53) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL1435391 | 0.85 | AGXT (0.58) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL7973999 | 0.85 | LMNA (0.63) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL11831663 | 0.85 | AGXT (0.58) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL29670114 | 0.85 | LMNA (0.63) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL22838174 | 0.83 | CYP1A2 (0.52) | AGXTKDM4EMAPK1TDP1RAB9A | |
| SCHEMBL14113223 | 0.83 | GPBAR1 (0.58) | AGXTKDM4EMAPK1TDP1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111051483-B | Esters and ethers of 2, 4-tetramethyl cyclobutane-1, 3-diol as fragrance chemicals | 巴斯夫欧洲公司 | 2025-01-24 | — | — | CN | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| EP-3884018-A1 | JASMOL | Symrise AG (DE) | 2021-09-29 | — | — | EP | claimed |
| CN-113056547-A | Jasmine alcohol | 西姆莱斯有限公司 | 2021-06-29 | — | — | CN | claimed |
| EP-3809876-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2021-04-28 | — | — | EP | claimed |
| WO-2020015880-A1 | BI-PHASE DEODORIZING COSMETIC COMPOSITION | BEIERSDORF AG (DE) | 2020-01-23 | — | — | WO | claimed |
| WO-2019243869-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2019-12-26 | — | — | WO | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-1894603-B1 | Encapsulation of bulky fragrance molecules | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| WO-2011147455-A1 | FLAVORING SUBSTANCE-INCLUDED COMPOUNDS | SYMRISE AG (DE) | 2011-12-01 | — | — | WO | claimed |
| JP-2008513896-A | — | — | 2008-05-01 | — | — | JP | claimed |
| US-20080059226-A1 | Methods and Systems for Preventing Diversion Of Prescription Drugs | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2008-03-06 | — | — | US | claimed |
| EP-1792180-A2 | METHODS AND SYSTEMS FOR PREVENTING DIVERSION OF PRESCRIPTION DRUGS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2007-06-06 | — | — | EP | claimed |
| WO-2006034367-A2 | METHODS AND SYSTEMS FOR PREVENTING DIVERSION OF PRESCRIPTION DRUGS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2006-03-30 | — | — | WO | claimed |
| US-20060062734-A1 | Methods and systems for preventing diversion of prescription drugs | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2006-03-23 | — | — | US | claimed |
| US-12630781-B2 | Fragrance or flavour mixture | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12625123-B2 | Device and method for the analytical and sensory determination of the release of an active substance from a release system | SYMRISE AG (DE) | 2026-05-12 | — | — | US | disclosed |
| EP-1067126-A2 | Tetracyclic acetals | HAARMANN & REIMER GMBH (DE) | 2001-01-10 | — | — | EP | disclosed |
| US-5236780-A | Substrate, surface treating layer, pressure rupturing microcapsules with perfume | BROTHER KOGYO KABUSHIKI KAISHA (JP) | 1993-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12625123-B2 | Device and method for the analytical and sensory determination of the release of an active substance from a release system | TAS2R7, TAS2R42, TAS2R39 | AGXT 2300/4885KDM4E 4421/4885MAPK1 3015/4885 |
| US-12630781-B2 | Fragrance or flavour mixture | NOTUM, FFAR2, FFAR1 | AGXT 1326/4885KDM4E 2767/4885MAPK1 2912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.